Edition:
India

Yabao Pharmaceutical Group Co Ltd (600351.SS)

600351.SS on Shanghai Stock Exchange

7.26CNY
8:59am IST
Change (% chg)

¥0.08 (+1.11%)
Prev Close
¥7.18
Open
¥7.17
Day's High
¥7.27
Day's Low
¥7.15
Volume
2,253,600
Avg. Vol
4,481,970
52-wk High
¥9.56
52-wk Low
¥6.97

Chart for

About

YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the... (more)

Overall

Beta: 0.78
Market Cap(Mil.): ¥6,217.63
Shares Outstanding(Mil.): 787.04
Dividend: 0.02
Yield (%): 0.25

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Yabao Pharma Sees 2017 Net Profit Up 788-818 Pct On Rising Sales Of High Margin Products

* SAYS IT SEES 2017 NET PROFIT UP 788-818 PERCENT Y/Y FROM 225.2 MILLION YUAN ($34.44 million) YEAR AGO Source text in Chinese: http://bit.ly/2l7xYmF Further company coverage: ($1 = 6.5385 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

25 Dec 2017

BRIEF-Yabao Pharma's controlling shareholder plans exchangeable bonds issue

* Says controlling shareholder plans to raise up to 500 million yuan ($75.33 million) in exchangeable bonds issue

10 Nov 2017

BRIEF-Yabao Pharmaceutical Group gets approval to conduct drug clinical trials for diabetes

* Says it gets an approval to conduct drug clinical trials of SY-008 which can be used for treatment of diabetes, from China Food and Drug Administration

31 Jul 2017

Earnings vs. Estimates